CS logo
small CS logo
Saint Joseph Regional Cancer Center

Bryan, Texas, United States
Cancer treatment center in Bryan, Texas
2215 E Villa Maria Rd, Bryan, TX 77802

About Saint Joseph Regional Cancer Center


"Cancer Center at St. Joseph Health - Bryan, TXis dedicated to delivering high quality, compassionate care to Bryan, TX and nearby communities. Visit us at2215 E Villa Maria Rdor call 9797740808for more information. Our physicians are committed to building long-lasting relationships with their patients and families. Our board-certified physicians provide continuous patient-centered care, while using the latest technology for diagnosis and treatment."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
68
SWOG Cancer Research Network
23
Alliance for Clinical Trials in Oncology
21
ECOG-ACRIN Cancer Research Group
16
Hoag Memorial Hospital Presbyterian
5
NRG Oncology
5
NSABP Foundation Inc
4
Radiation Therapy Oncology Group
3
Wake Forest University Health Sciences
3
Celgene
2
Children's Oncology Group
2
Total Rows: 19

Clinical Trials at Saint Joseph Regional Cancer Center


During the past decade, Saint Joseph Regional Cancer Center conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 39 clinical trials were completed, i.e. on average, 33.1% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 29 clinical trials were completed. i.e. 87.9% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111112121919191924242222111100114411445588Started TrialsCompleted Trails20152016201720182019202020210102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
1992-08-01
1999-02-01
Completed
Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer
1996-01-01
Unknown status
30
High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma
1996-01-01
2000-01-01
Completed
40
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma
1998-05-01
2000-01-01
Withdrawn
0
Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma
1998-06-01
2000-01-01
Withdrawn
0
Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy
1998-06-01
1999-06-01
Withdrawn
0
Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
2002-09-01
2009-01-01
Completed
602

Rows per page:

1–100 of 161

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Saint Joseph Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 68 trials, followed by "SWOG Cancer Research Network" with 23 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "Hoag Memorial Hospital Presbyterian" with 16 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 79 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer Biotherapy Research Group" with 5 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 27 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 68National CancerInstitute (NCI): 68SWOG Cancer ResearchNetwork: 23SWOG Cancer ResearchNetwork: 23Alliance for ClinicalTrials in Oncology: 21Alliance for ClinicalTrials in Oncology: 21ECOG-ACRIN CancerResearch Group: 16ECOG-ACRIN CancerResearch Group: 16Hoag Memorial HospitalPresbyterian: 5Hoag Memorial HospitalPresbyterian: 5NRG Oncology: 5NRG Oncology: 5NSABP Foundation Inc: 4NSABP Foundation Inc: 4Radiation TherapyOncology Group: 3Radiation TherapyOncology Group: 3Wake Forest UniversityHealth Sciences: 3Wake Forest UniversityHealth Sciences: 3Celgene: 2Celgene: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 79National CancerInstitute (NCI): 79NRG Oncology: 15NRG Oncology: 15Canadian Cancer Trials Group: 6Canadian Cancer Trials Group: 6Cancer BiotherapyResearch Group: 5Cancer BiotherapyResearch Group: 5North Central CancerTreatment Group: 3North Central CancerTreatment Group: 3SWOG Cancer ResearchNetwork: 3SWOG Cancer ResearchNetwork: 3American College ofSurgeons: 2American College ofSurgeons: 2Cancer and LeukemiaGroup B: 2Cancer and LeukemiaGroup B: 2Genentech, Inc.: 2Genentech, Inc.: 2Agenus Inc.: 1Agenus Inc.: 1

Clinical Trials Conditions at Saint Joseph Regional Cancer Center


According to Clinical.Site data, the most researched conditions in "Saint Joseph Regional Cancer Center" are "Breast Cancer" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials) and "Recurrent Ovarian Carcinoma" (5 trials). Many other conditions were trialed in "Saint Joseph Regional Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Saint Joseph Regional Cancer Center


Most popular intervention types in "Saint Joseph Regional Cancer Center" are "Drug" (125 trials), "Other" (80 trials), "Biological" (70 trials), "Procedure" (43 trials) and "Radiation" (24 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (36 trials), "Laboratory Biomarker Analysis" (34 trials), "Computed Tomography" (28 trials), "Nivolumab" (26 trials) and "Questionnaire Administration" (26 trials). Other intervention names were less common.

Clinical Trials Genders at Saint Joseph Regional Cancer Center


The vast majority of trials in "Saint Joseph Regional Cancer Center" are 131 trials for "All" genders, 24 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at Saint Joseph Regional Cancer Center


Currently, there are NaN active trials in "Saint Joseph Regional Cancer Center". undefined are not yet recruiting, 55 are recruiting, 71 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Saint Joseph Regional Cancer Center, 2 suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Saint Joseph Regional Cancer Center, 4 "Phase 1" clinical trials were conducted, 81 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 81Phase 2: 81Phase 3: 75Phase 3: 75Phase 1: 4Phase 1: 4Not Applicable: 3Not Applicable: 3Early Phase 1: 2Early Phase 1: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 71Active, not recruiting: 71Recruiting: 55Recruiting: 55Completed: 26Completed: 26Withdrawn: 3Withdrawn: 3Suspended: 2Suspended: 2Terminated: 2Terminated: 2Unknown status: 2Unknown status: 2